ISPOR - Global Cost Effective Analysis Of Apixaban Versus Warfarin For The Prevention Of Stroke As A Result Of Atrial Fibrillation- A Systematic Review

Full Text

Global Cost Effective Analysis Of Apixaban Versus Warfarin For The Prevention Of Stroke As A Result Of Atrial Fibrillation- A Systematic Review

Abstract

Authors

L Petrenchik N Hussain P Charles H Peprah FE Loh

Back to Volume 21, Supplemental S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now